logo.png
Autonomix Completes Licensing Transaction for FDA-Cleared Ablation Technology
24 juil. 2024 08h00 HE | Autonomix Medical, Inc.
RF Innovations’ Apex 6 Generator aligns with specifications required for Autonomix’s ablation system and facilitates ongoing development Transaction further reinforces Autonomix’s FDA regulatory...
IMI_2024_Lifestyle Imagery_Phase 1 Stock_2
Intuity Medical’s POGO Automatic®, the First and Only FDA-Cleared Automatic Blood Glucose Monitor, Now Covered by Medicare Part B
02 mai 2024 08h00 HE | Intuity Medical
FREMONT, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Intuity Medical, Inc., a medical technology company committed to making it easier to live with diabetes, announced today that its POGO Automatic®...
Hand 2USE this
Intuity Medical is Providing Insured People with Diabetes Easier Access to POGO Automatic Through HealthHavenRx™ eCommerce Partnership
11 avr. 2024 09h00 HE | Intuity Medical
FREMONT, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Intuity Medical, Inc., the medical technology company committed to making it easier to live with diabetes, is announcing a partnership with...
AXIM® Biotechnologies Commences Commercial Manufacturing of FDA-Cleared Proprietary Ocular Diagnostic Assays
11 avr. 2023 09h00 HE | AXIM Biotechnologies, Inc.
Leading Diagnostic Healthcare Company Begins Manufacturing of Ocular Immunoglobulin (IgE), Lactoferrin Tests to Fulfill Orders From Commercialization Partner SAN DIEGO, CA, April 11, 2023 ...
BransWay logo.jpg
BrainsWay Debuts “#TheRealOCD” Campaign and Video on Obsessive-Compulsive Disorder (OCD)
13 oct. 2020 09h00 HE | BrainsWay
CRESSKILL, N.J., Oct. 13, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders,...
BransWay logo.jpg
BrainsWay to Participate in Virtual Conferences Elevate by Psych Congress Virtual Experience and Online Obsessive-Compulsive Disorder (OCD) in July 2020
21 juil. 2020 09h00 HE | BrainsWay Ltd.
PATTERSON, N.J., July 21, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders,...
Logo.jpg
Endonovo Therapeutics Expands SofPulse® Sales to Plastic Surgery Centers
30 janv. 2020 07h00 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced sales of SofPulse® units to multiple Plastic Surgery...
Logo.jpg
Endonovo Therapeutics Announces First SofPulse® Sales to a Veterans Medical Center
27 janv. 2020 07h00 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, Jan. 27, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced initial sales of SofPulse® units into a VA hospital in...
sintx_grn_blk@4x-8.png
Amedica Receives Positive Nasdaq Listing Decision
01 déc. 2017 09h00 HE | Amedica Corporation
SALT LAKE CITY, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq: AMDA) (the “Company”), an innovative biomaterial company that develops and manufactures silicon nitride as a platform...
sintx_grn_blk@4x-8.png
Amedica Announces Adjournment of Special Meeting of Stockholders
03 oct. 2017 10h25 HE | Amedica Corporation
SALT LAKE CITY,, Oct. 03, 2017 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA), an innovative medical device company that develops and commercializes silicon nitride, announced that the...